Wells Fargo & Company Eton Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

$429 Billion
Q1 2025

A detailed history of Wells Fargo & Company transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 750 shares of ETON stock, worth $15,179. This represents 0.0% of its overall portfolio holdings.

Number of Shares

750

Previous 1,000 25.0%

Holding current value

$15,179

Previous $13,000 30.77%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$11.75 - $18.25 $2,937 - $4,562	-250 Reduced 25.0%	750 $9,000
Q4 2024 Feb 12, 2025	BUY	$5.9 - $13.15 $5,900 - $13,150	1,000 New	1,000 $13,000
Q1 2024 May 10, 2024	BUY	$3.48 - $5.03 $4,360 - $6,302	1,253 Added 728.49%	1,425 $5,000
Q4 2023 Feb 09, 2024	BUY	$3.45 - $4.66 $31 - $41	9 Added 5.52%	172 $0
Q3 2023 Nov 13, 2023	BUY	$2.55 - $5.63 $28 - $61	11 Added 7.24%	163 $0
Q2 2023 Aug 15, 2023	BUY	$3.32 - $4.04 $23 - $28	7 Added 4.83%	152 $0
Q1 2023 May 12, 2023	SELL	$2.89 - $4.1 $11,554 - $16,391	-3,998 Reduced 96.5%	145 $0
Q4 2022 Feb 13, 2023	BUY	$2.02 - $3.25 $8 - $13	4 Added 0.1%	4,143 $11,000
Q3 2022 Nov 14, 2022	BUY	$2.04 - $3.03 $2 - $3	1 Added 0.02%	4,139 $9,000
Q2 2022 Aug 12, 2022	SELL	$2.55 - $4.38 $8,889 - $15,268	-3,486 Reduced 45.72%	4,138 $11,000
Q1 2022 May 16, 2022	BUY	$3.43 - $4.69 $25,725 - $35,175	7,500 Added 6048.39%	7,624 $34,000
Q4 2021 Feb 14, 2022	BUY	$3.66 - $6.59 $3 - $6	1 Added 0.81%	124 $1,000
Q3 2021 Nov 15, 2021	SELL	$4.2 - $6.26 $1,327 - $1,978	-316 Reduced 71.98%	123 $1,000
Q2 2021 Aug 16, 2021	SELL	$5.71 - $8.85 $90,857 - $140,821	-15,912 Reduced 97.32%	439 $3,000
Q1 2021 May 13, 2021	SELL	$6.93 - $10.07 $67,345 - $97,860	-9,718 Reduced 37.28%	16,351 $120,000
Q4 2020 Feb 09, 2021	BUY	$6.65 - $8.83 $36,894 - $48,988	5,548 Added 27.04%	26,069 $212,000
Q3 2020 Nov 05, 2020	SELL	$4.96 - $9.06 $42,616 - $77,843	-8,592 Reduced 29.51%	20,521 $162,000
Q2 2020 Aug 13, 2020	BUY	$3.5 - $6.09 $91,140 - $158,583	26,040 Added 847.38%	29,113 $158,000
Q1 2020 May 14, 2020	BUY	$2.87 - $7.47 $8,819 - $22,955	3,073 New	3,073 $12,000

Others Institutions Holding ETON

# of Institutions

Shares Held

14M

Call Options Held

61.2K

Put Options Held

33.1K

View Full List

About Eton Pharmaceuticals, Inc.

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $512M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

More about ETON

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Eton Pharmaceuticals, Inc. Transaction History